News and Trends 1 Dec 2023 Arvinas raises $350 million; Exonate’s trial reaps success; new cancer drugs discovered …conditions and rare cardiac muscle diseases. AnaptysBio to acquire BDCA2 modulator antibody portfolio from Centessa Pharmaceuticals Immunomodulators are designed to treat autoimmune and inflammatory diseases by modifying the immune system… December 1, 2023 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 18 Feb 2025 T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments …to recognize and kill harmful cells, be it tumor cells in the case of cancer or autoreactive cells in the case of autoimmune diseases. They achieve this by binding to… February 18, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 1 Dec 2025 Stem cell therapy’s avant-garde: Eight companies leading the way …various cell types, hold great potential in regenerative medicine. Some notable advancements in stem cell therapy include its application in treating neurodegenerative diseases such as Parkinson’s disease. Companies like BlueRock Therapeutics have pioneered… December 1, 2025 - 11 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
More News! 14 Nov 2022 BioSenic’s autoimmune disease platform adapting to meet unmet medical needs …specializes in serious autoimmune and inflammatory diseases as well as cell repair. The update follows the announcement of the merger between Bone Therapeutics and Medsenic and the listing on Euronext… November 14, 2022 - 4 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 21 Nov 2017 French Biotech Steps Up Autoimmune Disease Drug Development with €14.5M Series A Step Pharma will use the proceeds of its first fundraising round to support the development of immunomodulators for autoimmune diseases towards the clinic. Step Pharma develops inhibitors targeting an enzyme… November 21, 2017 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
In Depth 18 Sep 2024 Two targets, one solution: The rise of bispecific antibodies …incidences of chronic diseases such as cancer, autoimmune disorders, and infectious diseases, rising demand for targeted therapies, as well as advancements in antibody engineering technologies, as being some of the… September 18, 2024 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 2 Aug 2022 Sosei Heptares and AbbVie enter second collaboration targeting neurological diseases A new drug discovery collaboration has taken place between Japanese Sosei Group Corporation and UK-based Abbvie with the hope of targeting neurological disease. This is the second partnership between the… August 2, 2022 - 2 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 30 Nov 2017 Qiagen Joins French Biotech to Build the Next Generation of Microbiome Technology …diseases, but they also have wider effects, modulating the immune system, metabolism and neurological function too. By better understanding its functionality, the microbiome could be used to treat diseases like… November 30, 2017 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 21 Mar 2019 UK Government’s Bid on Healthcare Genomics Already Benefiting Biotechs …The company uses machine learning to mine genomic data and predict the outcome of therapy for various diseases, with a focus on advancing personalized medicine. Using its technology, Genomics announced… March 21, 2019 - 5 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 12 Jul 2021 Sofinnova Taps into Italian Gene Therapy with Three Seed Financings …in seed funding to fuel the development of treatments for rare inherited diseases. Sofinnova’s move follows a €20M injection through the same fund last year in three other early-stage Italian… July 12, 2021 - 5 minutesmins - By Anita Chakraverty Share WhatsApp Twitter Linkedin Email
Best in Biotech 23 May 2025 Finland: Pushing biotech forward in the land of a thousand lakes …round in January 2025 Aplagon is developing novel treatments for thromboinflammatory diseases. Its lead candidate, APAC, is a first-in-class therapeutic designed to act locally at sites of vascular injury by… May 23, 2025 - 10 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 7 May 2025 Top biotech deals of April 2025 …of the latter’s bispecific antibodies, HXN-1002 and HXN-1003, to treat autoimmune and inflammatory bowel diseases. Earendil will receive $125 million upfront and is eligible to receive up to $1.72 billion… May 7, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email